Analyst consensus rating
Omega Healthcare Investors Analyst Rating: Buy
Direct answer
Omega Healthcare Investors's consensus rating is Buy.
18 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $51.89.
Forecast evidence checked September 5, 2026.
Get free Omega Healthcare Investors email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $46.38
- Average price target
- $51.89
- High price target
- $61.00
- Low price target
- $46.00
- Low target gap
- -0.8%
- Target upside
- +11.9%
- High target gap
- +31.5%
- Target range width
- 32.3%
- Consensus rating
- Buy
- Analysts
- 18
- Evidence date
- September 5, 2026
- Valid through
- September 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Omega Healthcare Investors?
Omega Healthcare Investors has a verified Buy consensus. The same dataset has an average price target of $51.89.
How far are Omega Healthcare Investors's low and high targets from the recorded price?
The low target implies -0.8%, while the high target implies +31.5%.
How many analysts are included in Omega Healthcare Investors's consensus?
The verified consensus includes 18 analysts.
How is Omega Healthcare Investors's target upside or downside calculated?
The average target of $51.89 is divided by the recorded price of $46.38, then one is subtracted to produce +11.9%. This does not guarantee a future return.
When was Omega Healthcare Investors's analyst forecast verified?
The data was verified on 2026-09-05. The dataset is valid through 2026-09-12.